| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 757,368 | 667,675 | 598,282 | 755,875 | | Cost of Revenue | 557,826 | 525,141 | 484,987 | 579,018 | | | Gross Profit | 199,542 | 142,534 | 113,295 | 176,857 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 201,041 | 222,465 | 203,434 | 217,955 | | Non Recurring |
-
| 2,777 | 2,341 | 325,445 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,499) | (82,708) | (92,480) | (366,543) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,319) | (1,732) | (1,575) | 718 | | Earnings Before Interest And Taxes | (2,818) | (84,440) | (94,055) | (365,825) | | Interest Expense | 9,557 | 6,211 | 728 |
-
| | Income Before Tax | (12,375) | (90,651) | (94,783) | (365,825) | | Income Tax Expense | (4,577) | (29,073) | (28,224) | (48,951) | | Minority Interest | (1,675) | (786) |
-
|
-
| | | | Net Income From Continuing Ops | (9,473) | (62,364) | (66,559) | (316,874) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,473) | (62,364) | (66,559) | (316,874) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,473) | ($62,364) | ($66,559) | ($316,874) |
|
0.27% Nasdaq 
Income Statement
